Advancements to Freeware ACD/Column Selector Help Take the Guess Work Out of Column Selection
Advanced Chemistry Development, Inc., (ACD/Labs) today announce the latest update to ACD/Column Selector, a freeware reversed-phase HPLC column selection tool. The latest upgrade increases the number of columns available for selection from 153 to 187, which will allow chromatographers to compare and contrast the latest columns, and help take the guesswork out of column selection.
ACD/Column Selector was created through a collaboration with Mel Euerby and Patrik Petersson of AstraZeneca. The freeware application was developed from over 3000 experiments characterizing the most commonly-used reversed-phase columns.
Patrik Petersson, PhD, Associate Principal Scientist at AstraZeneca, states, “ACD/Column Selector allows chromatographers to scientifically compare the most popular columns according to certain parameters (ligand density, hydrophobic selectivity, shape selectivity, hydrogen bonding capacity, total ion-exchange capacity, and acidic ion-exchange capacity). Users may identify equivalent columns (“backup columns”) as well as columns with widely differing characteristics to fully exploit selectivity differences in method development.”
Mike McBrien, M.Sc., Chromatography Product Manager at ACD/Labs, comments, “The team at AstraZeneca has done a tremendous job in characterizing the world’s most popular columns. It’s commendable that they’ve made this information available to the chromatographic community in this way.”
ACD/Column Selector is a free ChemBasic application that runs within freeware ACD/ChemSketch. Both ACD/Column Selector and ACD/ChemSketch may be downloaded from our website at: www.acdlabs.com/columnselector.
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com .
About AstraZeneca
AstraZeneca is one of the world’s leading pharmaceutical companies, dedicated to the discovery, development, manufacturing and marketing of high quality, effective prescription medicines that bring benefit for patients and add value for shareholders and wider society. Their medicines are designed to fight disease in important areas of medical need: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory & inflammation and are available in over 100 countries. Sales in 2005 totaled $24 billion, with an operating profit of $6.5 billion. They employ around 12,000 people in research and development at 11 R&D centres in seven countries: Sweden, the UK, the US, Canada, France, India and Japan. More information can be found at http://www.astrazeneca.com
<!–
ACD/Labs has been fueling the advancement of scientific research since 1998 by providing scientists access to our software tools. One of our primary goals has been to ensure that the academic community has access to a chemical structure drawing package enabling accurate representation of chemical structures and inclusion into lab reports. In order to facilitate standardization within an academic environment, we have offered site licenses of our drawing software together with our assistance to support the deployment process. With over 250 donations of site licenses to date, ACD/Labs’ software continues to provide a significant impact on a major segment of the academic scientific community.
Academic institutions worldwide have adopted ACD/ChemSketch—an advanced chemical structure drawing software—as an interactive teaching tool to simplify and convey chemistry concepts to their students. Among many other features, this product offers tautomer prediction, 2D structure cleaning, 3D optimization and viewing, and drawing of polymers, organometallics, and Markush structures. With the added InChI™ chemical nomenclature protocol compatibility, and access to PubChem, ACD/ChemSketch can be used to search chemical databases directly from the software interface according to structure or substructure searches. To date, over 270 academic institutions worldwide have chosen ChemSketch as their standard chemical drawing package, and over 600,000 chemists have downloaded the freeware version.
ACD/Labs offers a wide range of software tools for teaching and research. From the freeware chemical structure drawing package to the industry standard systematic naming tools, PhysChem, and NMR prediction software, ACD/Labs has an unsurpassed range of software products to facilitate academic research and make the teaching process interactive, memorable, and rewarding. ACD/Labs recently announced that the Department of Chemistry and Chemical Biology at Harvard University purchased a site license of ACD/2D NMR Processor which supports all major NMR formats and provides exceptional capabilities for desktop processing, analyzing, and interpretation. ACD/Labs has also provided Carnegie Mellon University, Stanford University, University of Michigan, University of Toronto, Oxford University, and numerous other academic facilities, with site-wide access to our prediction algorithms and databases via an Internet service.
Antony Williams, Ph.D., VP and Chief Science Officer at ACD/Labs, comments, “ACD/ChemSketch has become the freeware standard chemical structure drawing package for students in secondary schools, colleges, universities, and other educational establishments. Our site licensing program serves to assist academic organizations in standardizing on a platform for structure representation and exchange. Educators worldwide now make use of this platform for developing lesson plans and introducing their students to the benefits of chemistry software. We welcome the opportunity to support the professional scientists of tomorrow with our tools today.”
For more information on professional software for academia, please visit http://www.acdlabs.com/educators/research.html.
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
–>
